Evidence map›Paper›PMID 40587199›Full record

ArticleeLife2025

Tissue-specific responses to TFAM and mtDNA copy number manipulation in prematurely ageing mice.

Laura Sophie Kremer, Guanbin Gao, Giovanni Rigoni, Roberta Filograna, Mara Mennuni, Rolf Wibom, Ákos Végvári, Camilla Koolmeister, Nils-Göran Larsson

Abstract read
In one paragraph

Article in eLife, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Cooperative Architecture of Mitochondrial Proteome Homeostasis.medRxiv : the preprint server for health sciences · 2026
    Article
  6. Review
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Laura Sophie Kremer *Department of Medical Biochemistry and Biophysics, Karolinska Institutet, Stockholm, Sweden.ORCID https://orcid.org/0000-0002-1647-7538
Guanbin Gao *Department of Medical Biochemistry and Biophysics, Karolinska Institutet, Stockholm, Sweden.
Giovanni RigoniDepartment of Medical Biochemistry and Biophysics, Karolinska Institutet, Stockholm, Sweden.
Roberta FilogranaDepartment of Medical Biochemistry and Biophysics, Karolinska Institutet, Stockholm, Sweden.
Mara MennuniDepartment of Medical Biochemistry and Biophysics, Karolinska Institutet, Stockholm, Sweden.ORCID https://orcid.org/0000-0001-6199-6233
Rolf WibomCenter for Inherited Metabolic Diseases, Karolinska University Hospital, Stockholm, Sweden.ORCID https://orcid.org/0000-0001-6721-4642
Ákos VégváriDepartment of Medical Biochemistry and Biophysics, Karolinska Institutet, Stockholm, Sweden.
Camilla KoolmeisterDepartment of Medical Biochemistry and Biophysics, Karolinska Institutet, Stockholm, Sweden.
Nils-Göran LarssonDepartment of Medical Biochemistry and Biophysics, Karolinska Institutet, Stockholm, Sweden.ORCID https://orcid.org/0000-0001-5100-996X

Funding

Cancerfonden 21 1409 PjDiabetesfonden DIA2020-516Diabetesfonden DIA2021-620European Molecular Biology Organization ALTF 570-2019Hjärnfonden FO2021-0080Knut och Alice Wallenbergs Stiftelse 2019.0109Knut och Alice Wallenbergs Stiftelse 2023.0224Novo Nordisk Foundation Center for Basic Metabolic Research NNF20OC006316Novo Nordisk Foundation Center for Basic Metabolic Research NNF22OC0078444Vetenskapsrådet 2015-00418
6 · The paper itself

Abstract

Somatic mitochondrial DNA (mtDNA) mutations are implicated as important drivers of ageing and age-related diseases. Their pathological effect can be counteracted by increasing the absolute amount of wild-type mtDNA via moderately upregulating TFAM, a protein important for mtDNA packaging and expression. However, strong TFAM overexpression can also have detrimental effects as it results in mtDNA hypercompaction and subsequent impairment of mtDNA gene expression. Here, we have experimentally addressed the propensity of moderate TFAM modulation to improve the premature ageing phenotypes of mtDNA mutator mice, carrying random mtDNA mutations. Surprisingly, we detect tissue-specific endogenous compensatory mechanisms acting in mtDNA mutator mice, which largely affect the outcome of TFAM modulation. Accordingly, moderate overexpression of TFAM can have negative and beneficial effects in different tissues of mtDNA mutator mice. We see a similar behavior for TFAM reduction, which improves brown adipocyte tissue homeostasis, while other tissues are unaffected. Our findings highlight that the regulation of mtDNA copy number and gene expression is complex and causes tissue-specific effects that should be considered when modulating TFAM levels. Additionally, we suggest that TFAM is not the sole determinant of mtDNA copy number in situations where oxidative phosphorylation (OXPHOS) is compromised, but other important players must be involved.

Indexed as

Aging, PrematureDNA-Binding ProteinsDNA Copy Number VariationsDNA, MitochondrialGene DosageMitochondrial ProteinsTranscription FactorsAgingAnimalsHigh Mobility Group ProteinsMiceMutationOrgan SpecificityOxidative PhosphorylationDNA-Binding ProteinsDNA, MitochondrialHigh Mobility Group ProteinsMitochondrial ProteinsTfam protein, mouseTranscription Factorsbiochemistrychemical biologygeneticsgenomicsmitochondrial DNAmousemtDNA copy numbermtDNA mutationstissue specificity

Identifiers

PMID40587199
PMCPMC12208663

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.